Dr RR Baliga's "Got Knowledge Doc" Podkast

🫁 Stable—but not safe. Should we intervene before patients crash? PRAGUE-26 randomized 558 patients with intermediate-high–risk acute pulmonary embolism to catheter-directed low-dose alteplase + anticoagulation or anticoagulation alone. The 7-day composite of death, recurrent PE, or cardiorespiratory decompensation/collapse fell from 6.8% to 0.7% (RR 0.10; P—mainly through fewer episodes of decompensation. 🎯 Major bleeding was not increased, although 2 intracranial hemorrhages occurred with thrombolysis. 🩸 💡 The emerging paradigm: prevent the crash rather than rescue it.

🦪 Small Creatures, Mighty Nutrition, Global Impact Could aquatic invertebrates help close the global micronutrient gap? 🌊 A fascinating Nature study finds that current production supplies the equivalent annual requirements of vitamin B12 and selenium for >5 billion people—and copper, omega-3 fatty acids, iodine and zinc for >1 billion. 🦐 💡 Bivalves are particularly rich in iron, iodine, zinc and B12. But nutrition on paper is not nutrition on the plate: sustainability, safety, access, affordability and bioavailability matter. Tiny creatures. Enormous nutritional potential. 🌍

🫀 Cut the Signal, Cut the Risk? Could pulmonary-artery denervation change the trajectory of heart failure–related pulmonary hypertension? In PADN-HF-PH, 264 symptomatic patients were randomized to denervation + guideline-directed medical therapy or medical therapy alone. Clinical worsening at 2 years: 25.7% vs 51.5% (HR 0.49; P=0.006). ⚡ A provocative concept: pulmonary sympathetic overactivity may be a modifiable therapeutic target. 🎯 But no sham control, China-only enrollment, and mortality benefit remains unproven

🧬 Could semaglutide do more than treat obesity and diabetes? A fascinating study in aged female mice suggests that late-life semaglutide may act partly as a calorie-restriction mimetic—improving cognition, physical function and glucose control while attenuating multiple hallmarks of ageing. 🐭⏳ Most strikingly, median lifespan increased from 742 to 834 days. The biology implicates nutrient sensing, NAD⁺–sirtuin and insulin–IGF1 pathways.

🫀 Should we start a statin after age 70? STAREE delivers an important answer. In 9,971 adults ≥70 without cardiovascular disease, diabetes, or dementia, atorvastatin 40 mg reduced major cardiovascular events by 30% over 5.9 years (HR 0.70; NNT 37). 💊 Yet it did not prolong disability-free survival (HR 0.94). The benefit was driven largely by fewer myocardial infarctions and coronary revascularizations. 🎯 Take-home: age alone should not close the door on cardiovascular prevention—but preventing events is not the same as extending healthy life.

🌍 The Monk, the Manuscripts, the Medical Bridge How did Arabic medical knowledge reach medieval Europe? 📚🩺 Meet Constantine the African (c. 1010–1087)—North African physician, multilingual translator, and Benedictine monk at Monte Cassino. His Latin translations of major Arabic medical works helped transmit centuries of scholarship to Salerno and beyond. 🌉 His enduring lesson: medicine advances when knowledge crosses borders. 🎙️ Great Doctors Series — Dr RR Baliga's Podkast for the Kurious Doc. Where Curiosity Meets Clarity!

🫀 Atherosclerosis doesn't wait for middle age. In the REACT study of 16,808 adults without known ASCVD, silent plaque was found in 57.1% overall—and even in 8.7% of men and 6.7% of women aged 18–29. Plaque burden rose dramatically with age and increasingly involved multiple arterial territories. 🚨 Even more provocative: conventional 10-year risk classification identified only a minority with existing silent disease. Low predicted risk does not necessarily mean plaque-free arteries. 🔍 Prevention may need to think younger—and earlier. 

🫀 AF + just one stroke-risk factor: anticoagulate or not? The SINGLE-AF randomized trial tackled this common clinical gray zone. At 24 months, the composite of stroke, systemic embolism, major bleeding, or cardiovascular death occurred in 0.5% with a DOAC vs 1.5% without anticoagulation (HR 0.31; P=0.03). 🎯 ⚠️ Only 17 primary events occurred, so the effect estimate remains imprecise. Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.pdf 💡 Takeaway: SINGLE-AF strengthens the case for DOAC therapy in selected intermediate-risk AF patients—but individualized decision-making remains essential.

🫀 MI has been redefined—and the numbers are gone. The Fifth Universal Definition of Myocardial Infarction (2026) replaces the familiar numerical MI types with a clinically intuitive trio: 🔴 Primary MI — acute coronary pathology 🟢 Secondary MI — supply–demand imbalance from another acute illness 🔵 Procedure-related MI — complication of a cardiac procedure The crucial message? 🩸 Troponin elevation is myocardial injury—not automatically MI. Context, ischemia, ECG and imaging matter. 🎙️ Dr RR Baliga's Podkast for the Curious Doc: Where Curiosity Meets Clarity!

🫀💊 Can 4 doses help protect the kidney after cardiac surgery? MERCURI-2 randomized 784 patients to perioperative dapagliflozin or placebo. AKI within 7 days fell from 52% to 28%—RR 0.54, an absolute reduction of ~24% and NNT ≈4. 📉 Intriguingly, the signal was driven largely by urine-output–defined AKI; creatinine-only AKI was unchanged. Hard 30-day outcomes were also unchanged. 🎙️ A provocative new chapter in perioperative cardiorenal protection. 🛡️

💉 Shingles Shot, Heart Shield? 🛡️❤️ Could recombinant shingles vaccination protect more than the skin? In a natural experiment involving >72,000 matched adults ≥60 years, the recombinant vaccine was associated with 9% lower cardiovascular disease burden over 7 years, including lower burdens of ischemic heart disease and heart failure. 📉🫀 💡 Intriguingly, AS01-induced immune reprogramming and reduced IL-6 responses offer a potential mechanistic clue. ⚠️ Association ≠ causation—but this signal deserves randomized trials. #Cardiology #Vaccines #Prevention #MedicalPodcasts

🔎 Can you believe that meta-analysis? Meta-analyses sit near the summit of evidence-based medicine—but pooling more studies does not automatically produce more truth. 📊 Lee and colleagues offer a powerful clinical lesson: credibility requires alignment of evidence, methods, and inference. Ask first: Should these studies have been pooled at all? 🧠 Look for prospective planning, robust source data, adequate events, explainable heterogeneity, transparency, and honest uncertainty. 🎯 The goal? Fewer, better, more believable meta-analyses.

🩺 Avicenna: Medicine, Mind & a Millennium of Influence Nearly 1,000 years ago, Ibn Sina—Avicenna—was already asking questions that still animate medicine: How should we observe disease? How do reason and experience guide diagnosis? How are mind and body connected? 🧠 His monumental Canon of Medicine traveled from the Islamic world into European universities and influenced generations of physicians. 📖🌍 Meet the physician, philosopher & polymath whose curiosity refused to stay in one discipline. 🎙️ Great Doctors Series | Podkast for the Kurious Doc

🎯 Target the Tumor, Guard the Heart! ❤️ Antibody-drug conjugates are transforming breast cancer therapy—but precision oncology does not eliminate cardiovascular risk. 🧬🫀 This excellent JACC: CardioOncology Primer explores how the antibody, linker & payload may contribute to cardiotoxicity. HER2-directed ADCs carry the clearest cardiac signal, with T-DXd showing higher and more variable LVEF decline than T-DM1, while TROP-2–directed ADCs currently show limited cardiac signals. 🔑 The future: risk-based surveillance, biomarkers, AI prediction & smarter ADC engineering. #CardioOncology #BreastCancer #ADCs #Cardiotoxicity #MedicalPodcasts

🫀 Can vascular injury begin in your early 20s? Apparently, yes. In 1,283 young adults (mean age 22.9 years), ~79% had Stage 1–3 Cardiovascular-Kidney-Metabolic (CKM) syndrome. Higher CKM stage tracked with poorer Life's Essential 8 scores and greater carotid arterial injury. 🚨 Strikingly, even Stage 1—excess adiposity—was associated with thicker carotid intima-media. 🎯 The message for clinicians: young adulthood is not a vascular grace period. Primordial prevention must start early.

⏳ Can we measure aging before disease arrives? A fascinating Nature Medicine analysis puts epigenetic aging clocks to the test. Across 51 intervention studies and 3,128 blood samples, reliable next-generation clocks—particularly DunedinPACE and PCGrimAge—were the most responsive. 🧬 Pharmacologic interventions generated especially strong signals. Responsiveness of epigenetic aging biomarkers to longevity interventions in humans.pdf But here is the clinical pearl: a clock moving backward does not yet prove that the patient will live longer or healthier. ⚠️ Responsiveness is necessary for surrogacy—but not sufficient. News and Views Putting epigenetic aging clocks on trial.pdf 🎙️ Dr RR Baliga's Podkast for the Kurious Doc. Where Curiosity Meets Clarity!

🧬 Why do some people reach 100+ with remarkable resilience? Centenarians don't simply escape immune aging—they appear to adapt to it.  Preserved NK-cell function, altered T-cell populations, delayed autophagy decline, modulation of inflammageing, and distinctive transcriptomic, epigenetic and gut-microbial signatures may help maintain immune homeostasis. 💯🛡️ Fascinating lessons from nature's longest-lived humans—and perhaps clues for extending healthspan, not merely lifespan. 🔬♻️

🎨 Repigment, Reframe, Restore: A New Era for Vitiligo Vitiligo is far more than a cosmetic condition. In two phase 3 Viti-Up trials, oral upadacitinib 15 mg significantly improved facial and total-body repigmentation at 48 weeks. 💊 But here is the deeper lesson: better pigmentation ≠ complete patient benefit. Only 13–15% reported their vitiligo as "a lot less" or "no longer" noticeable. 👁️ The future of vitiligo care must measure not only pigment, but also dignity, mental health, long-term safety and access. 🧠❤️ #Vitiligo #Dermatology #JAKInhibitors #MedicalPodcasts

🧬 Detect, Decode, Decide: The Promise of Liquid Biopsy Can a blood test tell us what cancer is doing before imaging can? 🩸 Circulating tumor DNA (ctDNA) can identify actionable variants, track treatment response, detect resistance, and reveal molecular residual disease. In colorectal cancer, molecular relapse was detected ~8.7 months earlier than with imaging surveillance. 🔬 But important questions remain: when should we test, how often, and should ctDNA positivity alone trigger treatment?

🩺 Great Doctors Series: Rhazes (c. 865–925 CE) More than 1,000 years ago, Persian physician Rhazes (Al-Razi) practiced a remarkably modern kind of medicine: observe the patient, question authority, compare outcomes, and care for everyone—rich or poor. 🔬 He distinguished smallpox from measles, pioneered writing on childhood disease, challenged Galen when observations disagreed, and profoundly influenced medical education in Europe. 📚🌍 His timeless prescription? Observe carefully. Question courageously. Care compassionately. ⚕️

⚡ Short Sprints, Big Signals: How Exercise Intensity Changes the Message Exercise may be more than movement—it may be an interorgan conversation. 🧬🫀 A fascinating human multi-omics study shows that sprint-interval exercise produces broader and faster changes in circulating proteins and metabolites than moderate-intensity exercise. Muscle and adipose tissue appear central to this molecular dialogue, while many sprint-responsive proteins are associated with favorable cardiometabolic outcomes. 💡 Perhaps exercise intensity is not simply "more effort"—it is a different biological signal. 🏃‍♂️ When muscles sprint, the whole body may listen.

🧠❤️ The aging heart does not age alone. The 2026 ACC Scientific Statement reminds us that cardiovascular disease, cognitive impairment, and frailty are intertwined manifestations of biological aging. Cognitive Impairment and Frailty in Older Adults With Cardio vascular Disease- 2026 ACC Scientific Statement.pdf For clinicians, the message is practical: 🔍 screen cognition and frailty, 🚶 assess gait and strength, 🏋️ build resilience through multidomain exercise, 🥗 optimize nutrition, and 💊 reduce unnecessary medication burden.  ❤️ The goal is bigger than survival: preserve cognition, function, and independence.

🫀 The infarct ends. The risk doesn't. After myocardial infarction, atherosclerosis, thrombosis, inflammation, depression, deconditioning—and declining adherence—can sustain risk for decades. Our editorial proposes Persistent Prevention: 🔄 reassess evolving risk, 🎯 treat residual risk, 💊 sustain therapy when indicated, 🏃 prioritize cardiac rehabilitation, and 🧠 address psychosocial health. The goal: move from a static discharge bundle to a dynamic, lifelong prevention plan. ❤️ #Cardiology #MyocardialInfarction #Prevention

🧠🔀 Blend, Switch, Pursue: How the Brain Juggles Goals Must we choose one goal at a time? Apparently not. A fascinating Nature study suggests the brain continuously blends competing goals. 🎯 Using control theory and human intracranial recordings, investigators reveal a striking division of labor: 🧭 hippocampus estimates and updates the policy state, 🔀 anterior cingulate cortex anticipates major switches, and ⚖️ orbitofrontal cortex provides value context. A compelling bridge between engineering, neuroscience, and real-world executive behavior. 🧠⚙️

🧠 Can we "replumb" the brain to fight Alzheimer's? A provocative procedure—deep cervical lymphatic–venous anastomosis (dcLVA)—connects neck lymphatics to veins in an attempt to enhance brain-waste clearance. Early reports describe improvements in cognition and biomarkers, but the evidence remains limited and durability uncertain. A controversial Alzheimer's surgery is said to reverse symptoms — here's what scientists know _ Nature.pdf 🔬 Randomized and even sham-controlled trials are now putting this extraordinary hypothesis to the test.

🦴 Hip fractures remain one of the most devastating injuries in older adults. This outstanding JAMA review summarizes the latest evidence on epidemiology, diagnosis, surgery, rehabilitation, osteoporosis treatment, and fall prevention. Key messages include the importance of timely surgery, early mobilization, comprehensive rehabilitation, and aggressive secondary fracture prevention to improve survival and preserve independence. I have distilled the paper into concise educational resources, infographics, and podcast-ready content for busy clinicians. 🎙️📚 #HipFractures #Osteoporosis #Geriatrics #Orthopedics #MedicalEducation #MedicalPodcasts

🌿 Could a physician writing over 1,700 years ago help inspire a Nobel Prize–winning discovery? Ge Hong (283–343 CE) was far more than an alchemist. In Emergency Formulae at an Elbow's Length, he emphasized practical medicine, first aid, careful observation, and experimentation. His description of Artemisia annua for malaria later inspired the work that led to artemisinin and the 2015 Nobel Prize. 🏆 In this episode of the Great Doctors Series, discover how curiosity, resilience, and evidence-based thinking allowed Ge Hong's ideas to echo across the centuries. ⚕️📜 #MedicalHistory #GeHong #TraditionalChineseMedicine #FirstAid #Artemisinin #MedicalEducation #GreatDoctors #MedicalPodcasts #HistoryOfMedicine

🩺 Why do patients faint—and who is at highest risk? This outstanding NEJM Clinical Practice review provides a practical, evidence-based approach to syncope, emphasizing meticulous history taking, orthostatic blood pressure measurement, ECG, risk stratification, and mechanism-directed management. It also highlights the close relationship between syncope and unexplained falls in older adults, helping clinicians identify patients who require urgent evaluation while avoiding unnecessary hospitalization. 🎙️ #Syncope #Cardiology #EmergencyMedicine #MedicalEducation #NEJM #MedicalPodcasts

🍯🧠 Did sugar help build the human brain? This fascinating Science review challenges the long-held belief that meat alone drove human evolution. The authors argue that natural sugars from fruits and honey—and later cooked starch—provided the glucose essential for our expanding brains, reproduction, and survival.  The review integrates metabolism, anthropology, genetics, archaeology, and nutrition into a compelling new framework for understanding our evolutionary journey. A thought-provoking read for clinicians, scientists, and anyone interested in human origins. #HumanEvolution #Nutrition #MedicalPodcasts #Science

The new 2026 ACC Concise Clinical Guidance highlights why influenza, COVID-19, pneumococcal, RSV, and shingles vaccines should be considered an essential part of cardiovascular prevention. Strong evidence shows reductions in hospitalization, myocardial infarction, heart failure, stroke, and even mortality in selected populations. Prevention extends beyond statins and blood pressure control—it also includes timely immunization. 🎙️ In this episode of Dr RR Baliga's Podkast for the Kurious Doc, we explore the evidence, practical recommendations, and clinical pearls every cardiovascular clinician should know. #Cardiology #Vaccines #PreventiveCardiology #MedicalEducation

🫀 Can multivessel CABG be performed through a small thoracotomy without sacrificing safety? The randomized MIST Trial published in The Lancet suggests the answer is yes—for carefully selected patients treated by experienced teams. Patients undergoing minimally invasive CABG experienced faster physical recovery at 1 month, fewer transfusions, and shorter ventilation times, with no apparent safety penalty through 12 months. An important trial that shifts attention toward patient-centered recovery after cardiac surgery. 🎙️ #CardiacSurgery #CABG #MinimallyInvasiveSurgery #EvidenceBasedMedicine #MedicalEducation

🧬 Can one rare gene reshape our approach to metabolic disease? A remarkable Nature study analyzing more than one million individuals identifies FNIP1 as a key regulator of energy metabolism. Rare loss-of-function variants were associated with healthier lipid profiles, lower liver fat, improved glycaemia, favorable fat distribution, and substantially lower cardiometabolic disease risk. Mechanistic studies in human hepatocytes and mice strengthen the biological story, making FNIP1 an exciting potential therapeutic target. A fascinating example of how human genetics can illuminate tomorrow's treatments. 🚀🫀 #Nature #Genetics #Cardiology #Metabolism #PrecisionMedicine

🫀 Can fixing the lymphatic system slow mitral valve degeneration in Marfan syndrome? This elegant JCI study identifies defective lymphangiogenesis and reduced ZFP36-mediated anti-inflammatory signaling as previously unrecognized drivers of myxomatous mitral valve disease. In a mouse model, restoring lymphatic function with VEGF-C156S or activating ZFP36 with fingolimod reduced inflammation and valve thickening, opening an exciting avenue for disease-modifying therapies. A fascinating mechanistic advance with real translational promise. 🎙️ #Cardiology #MarfanSyndrome #ValveDisease #Lymphatics #MedicalResearch

🩺 Can a physician diagnose disease simply by feeling your pulse? Nearly 1,800 years ago, Wang Shuhe (c. 180–270 CE) transformed pulse-taking into a systematic science through the Maijing (The Pulse Classics). His work shaped Traditional Chinese Medicine for centuries and emphasized that careful observation often reveals what technology cannot. 📖 In this episode of the Great Doctors Series, we explore how one physician elevated diagnosis into an art—and why attentive listening remains one of medicine's greatest skills. 👋⚕️ #MedicalHistory #TraditionalChineseMedicine #PulseDiagnosis #MedicalEducation #GreatDoctors #MedicalPodcasts #Medicine #HistoryOfMedicine

🥩 Can eating less protein promote healthier aging? This comprehensive review examines how protein restriction—and specifically limiting methionine, isoleucine, and valine—modulates key longevity pathways including FGF21, GCN2, and mTOR. Experimental evidence consistently demonstrates improvements in metabolic health, mitochondrial function, senescence, and lifespan, while early human studies suggest favorable metabolic effects. Although long-term clinical outcome data are still needed, the review challenges conventional assumptions that "more protein is always better." A fascinating update for clinicians and researchers interested in nutrition, aging, and precision medicine. 🎙️ #Longevity #Nutrition #HealthyAging #MedicalResearch

🌍 Why is the global LDL-C burden still rising despite decades of progress? The latest JAMA Global Burden of Disease 2023 analysis reveals a striking paradox: age-standardized cardiovascular risk attributable to LDL-C has fallen, yet absolute deaths and disability continue to increase because of population growth and aging. The message is clear—earlier detection, broader access to statins, and stronger preventive strategies remain essential, particularly in middle-income countries. 🫀📉

🫀 Can the gut microbiome trigger atrial fibrillation? This elegant JCI study suggests that the microbial metabolite trimethylamine N-oxide (TMAO) is independently associated with AF and mechanistically promotes arrhythmia through muscarinic receptor–mediated autonomic dysfunction. In multiple mouse models, inhibiting microbial TMA production delayed AF onset and attenuated atrial remodeling. While clinical intervention studies are still needed, the work highlights the gut–heart axis as a promising preventive target for AF. A fascinating glimpse into the future of cardiovascular therapeutics. 🔬🦠💓

🫀❤️ Does the heart have its own "little brain"? This remarkable Cell study identifies two distinct intrinsic cardiac neuron populations with complementary roles: Npy⁺ neurons maintain baseline cardiac function and coronary perfusion, while Ddah1⁺ neurons preserve electrical stability during extreme stress. The work opens the door to cell-type–specific neuromodulation for arrhythmias, heart failure, and sudden cardiac death. A fascinating glimpse into the future of neurocardiology. 🎙️🔬 #Cardiology #Neurocardiology #HeartBrainAxis #MedicalEducation #MedicalPodcasts

🧬 Can changing just one essential amino acid influence aging?   This fascinating Nature Aging study found that lifelong dietary valine restriction improved metabolic health, reduced frailty, lowered cellular senescence and cancer burden in both sexes, and increased median lifespan by 23% in male mice. The work suggests that amino acid composition—not simply total protein intake—may be a key determinant of healthy aging.   While these findings are limited to mice, they provide compelling mechanistic insights and an exciting direction for precision nutrition research. 🎙️ #HealthyAging #Longevity #NutritionScience

💨 Can your breath reveal how efficiently you're burning fat? A new study describes a smartphone-assisted handheld breath acetone detector that enables accurate, non-invasive monitoring of fat metabolism at home. Validated against laboratory mass spectrometry, the device tracked metabolic responses to exercise, ketogenic diets, and fasting while demonstrating excellent agreement with reference testing. This technology could complement continuous glucose monitoring and advance personalized metabolic care, obesity management, and preventive medicine. 📱🧬🏃‍♂️ #DigitalHealth #Metabolism #PrecisionMedicine #MedicalPodcasts

🩺 Great Doctors Series | Hua Tuo (c. 140–208 CE) Centuries before modern anesthesia, Hua Tuo was described as using a herbal anesthetic, performing surgery, advancing acupuncture, and creating the famous Five Animal Exercises (Wuqinxi). His remarkable story blends innovation, compassion, and scientific curiosity, making him one of history's most influential physicians. Join me as we explore the life and legacy of this extraordinary medical pioneer in the latest episode of the Great Doctors Series. 🎙️ Dr RR Baliga's Podkast for the Kurious Doc – Where Curiosity Meets Clarity! #MedicalHistory #HuaTuo #TraditionalChineseMedicine #MedicalPodcasts #GreatDoctors #Innovation #Surgery #Acupuncture #MedicalEducation

🧬 Can chemical protein aging be reversed? This fascinating study introduces CMLase, an engineered enzyme that removes Nε-carboxymethyl-lysine (CML)—a stable advanced glycation end product (AGE) long believed to be irreversible. Ex vivo, CMLase repaired AGE damage in aged human lens, skin, and arterial tissues, providing the first proof-of-concept that age-related protein damage may be enzymatically reversible. While clinical translation remains distant, this work opens an exciting new frontier in regenerative medicine and healthy aging. 🎙️ #Aging #ProteinRepair #RegenerativeMedicine #MedicalPodcasts

🫀 HFpEF has entered a new era. The 2026 ACC Expert Consensus Decision Pathway highlights a practical approach to diagnosing HFpEF, distinguishing mimics, applying diagnostic scoring systems, and implementing evidence-based therapies including SGLT2 inhibitors while aggressively managing comorbidities. The accompanying infographic distills the guideline into high-yield clinical pearls for busy clinicians. This serves as a quick reference at the point of care. 📚❤️ #Cardiology #HeartFailure #HFpEF #MedicalEducation #Guidelines #EvidenceBasedMedicine #MedicalPodcasts

🧬🫀 Can successful gene therapy still leave the heart vulnerable? A fascinating NEJM correspondence describes a patient with Duchenne muscular dystrophy who developed early and delayed cardiotoxicity after microdystrophin gene therapy. Despite higher cardiac vector copy numbers, myocardial microdystrophin expression remained low and heterogeneous, raising important questions about efficacy, safety, and long-term surveillance. An important reminder that motor improvement may not mirror cardiac benefit. Join me as I unpack the clinical implications on Dr RR Baliga's Podkast for the Kurious Doc—Where Curiosity Meets Clarity! 🎙️🫀

🧬 Can a thymus-derived peptide help overcome age-related resistance to cancer immunotherapy? A fascinating new study identifies thymulin as a key regulator of age-associated inflammation. In preclinical models, thymulin reduced pro-inflammatory myeloid activity, inhibited NF-κB signaling, enhanced T-cell immunity, and restored responsiveness to anti-PD-L1 therapy in aged hosts. While clinical translation remains to be established, the work highlights the intriguing thymus–myeloid axis as a potential therapeutic target in older adults with cancer. 🎙️ More insights on Dr RR Baliga's Podkast for the Kurious Doc—Where Curiosity Meets Clarity!

☕❤️ Does coffee help—or harm—the heart? The latest American Heart Association Scientific Statement reviews the evidence behind caffeine and cardiovascular disease. The take-home message is reassuring: moderate coffee consumption (≈3–5 cups/day or ≤400 mg caffeine/day) is generally safe for most adults and is associated with lower risks of coronary artery disease, heart failure, stroke, atrial fibrillation, hypertension, and type 2 diabetes. The caution? High-dose energy drinks are a different story. Join me as we separate myths from evidence—one cup at a time. ☕🫀🎙️ #Cardiology #Coffee #Caffeine #HeartHealth #EvidenceBasedMedicine #MedicalEducation #MedicalPodcasts #PreventiveCardiology #AHA #PhysicianEducation

🫀 Could tiny plastic particles become the next major cardiovascular risk factor? A fascinating new European Heart Journal study found that micro- and nanoplastics were detected most frequently in patients presenting with ST-segment elevation myocardial infarction, alongside higher inflammatory markers, smoking exposure, and PM2.5 pollution. While causality remains unproven, the accompanying editorial positions plastics as an emerging component of the cardiovascular exposome. 🌍 This research reminds us that protecting heart health may increasingly require reducing environmental exposures—not just traditional risk factors. #Cardiology #EnvironmentalHealth #MedicalPodcasts #HeartDisease #Prevention

🌿 Great Doctors Series | Zhang Zhongjing (c. 150–219 CE) Long before antibiotics and modern epidemiology, Zhang Zhongjing transformed medicine through careful observation, precise diagnosis, and individualized treatment. His Shanghan Zabing Lun became one of the most influential medical texts in history and laid the foundation for the Cold Damage School of Traditional Chinese Medicine. His emphasis on treating the patient—not just the disease—continues to inspire physicians nearly 1,800 years later. A timeless lesson in clinical reasoning, compassion, and evidence-informed practice. 📜⚕️🌏 #MedicalHistory #TraditionalChineseMedicine #ClinicalReasoning #GreatDoctors #MedicalEducation #HistoryOfMedicine #MedicalPodcasts

🩺 Can dual antithrombotic therapy after PCI be safely shortened to just 1 month in patients with atrial fibrillation? The OPTIMA-AF trial suggests that an earlier transition to DOAC monotherapy significantly reduces clinically relevant bleeding while maintaining similar protection against death and thromboembolic events. Although the findings require confirmation in broader populations, this study could influence how we individualize antithrombotic therapy after PCI. 🎙️ In this episode of Dr RR Baliga's Podkast for the Kurious Doc, we review the trial, its clinical implications, and the important caveats for everyday practice. #Cardiology #AtrialFibrillation #PCI #MedicalEducation

🫀 Should dual antiplatelet therapy continue beyond 12 months? The DAPT-MVD trial (NEJM 2026) suggests that carefully selected patients with multivessel coronary artery disease who remain event-free after one year of therapy may benefit from another 12 months of clopidogrel plus aspirin. The result? Fewer cardiovascular events—driven largely by fewer myocardial infarctions—without more clinically relevant bleeding in this low-bleeding-risk cohort. ⚖️ A timely reminder that the future of DAPT lies in precision patient selection, not a one-size-fits-all approach. 🩺📚 #Cardiology #DAPT #MedicalEducation #MedicalPodcasts #NEJM